Market Herald logo


Be the first with the news that moves the market

Sona Nanotech Inc. is pleased to announce that it has received the third set of results of an independent assessment of its proprietary gold nanorod nanoparticles from the U.S. National Cancer Institute’s Nanotechnology Characterization Laboratory. In addition to running similar assessments to those that have been previously announced for contamination and endotoxin levels, this assessment included an analysis of the surfactant residue present following the chemical reaction necessary for the manufacture of Sona’s proprietary gold nanorods.

This is sponsored content issued on behalf of Sona Nanotech, please see full disclaimer here.

More From The Market Herald

Maritime Launch unveils new program at Spaceport Nova Scotia

Maritime Launch Services Inc. (NEO:MAXQ) unveiled its suborbital launch program currently scheduled to begin during Q2 2024.

ESE Entertainment notches collaboration for Web3 Game Arena

ESE Entertainment (TSXV:ESE) has notched a collaboration agreement with Poznan Game Arena and Metapro to organize the Web3 Game Arena.

An AI platform that can manage weight loss and addiction

Vice Health and Wellness (CSE:VICE) is developing an AI platform to provide a personalized weight loss and management experience.